|
What is
Basal Cell Cancer?
Basal Cell
Cancer is the most common type of cancer worldwide.
About 1 million cases of Basal Cell Cancer are
estimated to occur annually in the United States in
2005.
Thankfully, this form of skin cancer is readily
curable. Basal Cell cancer occurs as a result of the
combination of chronic sun exposure and genetic
susceptibility. Those patients with blue eyes and
freckles, who easily burn and have a history of
blistering sunburns are more likely to develop this
type of skin cancer. What is troublesome about Basal
Cell Cancer is that often patients are unaware of
any symptoms. For this reason, it is important that
self skin examinations are performed every few
months and that a comprehensive skin exam is
performed by your dermatologist on a yearly basis.
If you are diagnosed with this type of cancer, close
follow up by your doctor is essential as there is a
20-40% chance of your developing a second similar
cancer within within five years.
Basal Cell
Carcinoma- the most common of the skin cancers,
is characterized by a non-healing ulcer or papule
with a "rolled border" and prominent blood vessels.
Fig. 1
How do I
recognize Basal Cell Cancer?
Basal Cell
Cancer can present in a multitude of ways. Often a
nonhealing lesion can be the earliest sign of a
newly formed tumor. Bleeding, pain, tingling, and
itching can also be very early symptoms. Tumors can
either appear as an inconspicuous red bump with a
central dimple or depression or a simple benign flat
red region on the skin. When an ulcer or crust is
present, bleeding is often a common complaint.
If a
non-healing lesion such as those described above
occurs on your skin, it is advisable to have your
dermatologist assess the area as soon as possible,
especially if you have had extensive sun exposure or
a personal or family history.
Basal Cell
Carcinoma-Nodular variant is the most common
subtype
Fig. 2
Does Basal
Cell Cancer spread internally? Am I in danger?
This question
is often asked and can be divided into two parts.
First, the good news. This type of cancer does not
usually metastasize or spread to other organs. The
second aspect of this question, however, recognizes
that these tumors can become a destructive force.
Basal Cell cancer, if left untreated, can become
invasive and grow deep into the skin and underneath
structures. This process can result in a disfiguring
appearance and even the destruction of a sensory
organ such as the ear, eye or nose. Therefore,
especially on the on the head and neck areas, these
cancers need to be treated early and aggressively.
Scar-Like (Morpheaform)
Basal Cell Carcinoma-very destructive
Fig. 3
What are the options for
treatment of Basal Cell Cancer?
The mainstay
therapy for Basal Cell cancer is surgery. Newer
treatments involving chemotherapy with medications
that have a boosting effect on your immune system
such as Imiquimod (Aldara ™) (See Below) are proving
to be promising for certain less invasive basal cell
cancers. The mainstay procedure, however, is still
surgical excision or electrically destroying the
tumor (EDC or Laser procedures) which yields a cure
rate of about 95%. These latter techniques are
performed under local anesthesia and recovery time
is minimal. In certain instances, where the cancer
is close to a sensory organ such as the nose or eye,
a tissue sparing technique called
Mohs Surgery
may be employed. This type of surgery involves the
evaluation of multiple frozen specimens to make sure
that these important areas are free from residual
cancer. It has abou a 99% cure rate and is used for
tumors in the head and neck region primarily.Finally, some
doctors treat basal cell cancers with injectable
medications such as interferon or Bleomycin but
these treatments are still in the experimental
stage.
NEW
TREATMENTS FOR BASAL CELL CANCER
For early and
limited basal cell cancer,
Imiquimod (Aldara™) cream
can be used to
eliminate the cancer. This saves patients from
surgery and leads to an excellent cosmetic result.
For more information about Aldara ™ nonsurgical
treatments, please inquire about this at your next
appointment.
Fig 4.
Basal Cell Cancer-under the microscope
|